A recent study reveals that people who discontinue popular slimming jabs like Mounjaro or Wegovy may regain shed pounds far faster than those who end traditional diet and exercise plans.
Research printed in a major medical journal demonstrates that while obese individuals often shed a large proportion of their total mass while using the jabs, the weight returns at an average rate of nearly a kilo each month once they quit.
"Individuals using these treatments must be cognizant of the danger of fast rebound weight gain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.
That rate of recovery implies a return to starting mass within about 18 months.
Analyzing Therapies
The research, which examined dozens of trials involving over 9,000 of participants, contrasted the effects of these new drugs with conventional dieting.
Researchers point out that people who shed pounds through lifestyle changes alone generally see a slower weight regain—approximately 100 grams monthly—post-intervention.
Explaining the Rapid Rebound
Nutrition scientists suggest the mode of action of the jabs is key to understanding the heightened rebound.
GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production could lead to the system to produce less of its endogenous hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' results in appetite is no longer kept in check, making excessive eating far more likely."
A Chronic Disease?
Health authorities recommend the jabs for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.
Many experts contend that, due to the high risk of weight regain, the treatment might need to be life-long.
This opinion is echoed by pharmaceutical companies, who say that the findings "highlight the chronic nature of obesity," comparing it to managing diseases like hypertension.
User Accounts
Users who have stopped the jabs report a intense return of hunger.
"It felt as if a switch activating and you become ravenous," said an individual.
The struggle is compounded if individuals have not developed lasting dietary or behavioural changes during therapy.
Significant Adoption
Figures show that millions of people in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is more common among females than males.
- The middle-aged age group shows the greatest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, experts stress that while the jabs are potent agents for shedding pounds, they are not a magic solution and lasting health benefits hinges on combined behavioural support.
